Advertisement

Topics

AstraZeneca Puts Bicycles To Work In Multitarget Deal

21:58 EST 1 Dec 2016 | SCRIP

AstraZeneca has entered a broad early stage collaboration with Bicycle Therapeutics to discover and develop bicyclic peptides (Bicycles). If all...

      

Related Stories

 

Original Article: AstraZeneca Puts Bicycles To Work In Multitarget Deal

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca Puts Bicycles To Work In Multitarget Deal"

Quick Search
Advertisement
 

Relevant Topics

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...